Pharmacy Podcast Network

Ransomware; being held hostage from your own information and your own data. It’s in the news every day, generally large businesses, and banks, but it happens to every type and size of business every day. With complex schemes, malicious deception, various access points, complex research, and impersonation- ransomware is a worldwide threat that often funds nefarious dealings like terrorism, oppressive government and even the development of more ransomware. Today Jeff Hedges, the Pharmacy Compliance Guide and owner of R.J. Hedges & Associates and Nick Dorazio, Present of LVTech and technology expert are going to talk about what ransomware is and how it happens, put some context around the shear cost of this type of event happening to your business, we’ll go over some terminology and solutions for your business and even how you can prevent this from happening to your system.  https://www.rjhedges.com/ Learn more about your ad choices. Visit megaphone.fm/adchoices

Anesthesia providers need easy access to medications in the operating room. Pharmacy needs to keep medications secure. Achieving that delicate balance in the OR pressure cooker between access and accountability requires an aligned vision, dynamic communications, and enabling closed-loop technology. Participants Host:  Ken Perez, Vice President, Healthcare Policy and Government Affairs, Omnicell, Inc. Guest Expert:  Dr. Patrick Guffey, MD, MHA, CMIO, Performance Improvement & Informatics Officer, Children's Hospital Colorado For all the 'Future of Pharmacy' podcast episodes, click here: https://www.omnicell.com/podcast Learn more about your ad choices. Visit megaphone.fm/adchoices

Resources from the National Multiple Sclerosis Society  ·       Ask an MS Expert Webinar Series weekly on Fridays from 1-1:30pm ET   ·       COVID-19 and MS Information Center  Learn how Surescripts solutions are helping to revolutionize the specialty medications experience   Surescripts blog posts on pharmacy and specialty medications  ·       The Rise of Pharmacy to the Front Lines of Care and Innovation  ·       Avoiding Specialty Pharmacy Detours featuring findings from a Surescripts study in partnership with Accredo  ·       An Exercise In Trust: One Multiple Sclerosis Patient’s Journey  Relevant UN-Scripted Podcast Episodes  ·       The Future is Now for Specialty Medications  ·       A Day in the Life of a Specialty Pharmacist  Press Releases  ·       Surescripts Further Streamlines Specialty Prescribing Process With New Services For Specialty Pharmacies  ·       Specialty Pharmacists Report Process Delays of Up To 10 Days To Get Patients Started On Treatment  Learn more about your ad choices. Visit megaphone.fm/adchoices

PART 2 During the 2021 NCPA Annual Conference, Todd Eury leads a panel discussion of Pharmacy Owners who provide insights to leveraging RxSafe technologies in their pharmacies & enhancing patient medication adherence. Learn more about your ad choices. Visit megaphone.fm/adchoices

PART ONE During the 2021 NCPA Annual Conference, Todd Eury leads a panel discussion of Pharmacy Owners who provide insights to leveraging RxSafe technologies in their pharmacies & enhancing patient medication adherence. Learn more about your ad choices. Visit megaphone.fm/adchoices

The additional receptor implicated in Sars-COV-2's entry process, while not exactly new, is definitely not getting the fair share of the spotlight with ACE2. Involved in many complicated pathways in normal physiology, new research points to interesting possibilities for the future of pain treatment.  This is NOT your physician's podcast. Hosts Shane Garrettson and Cal Vandergrift dive into the pharmacy world with fun, interesting, and downright weird topics! Tune in for NEW episodes, available on Spotify, Apple, Anchor, and more! Check out our Facebook, Twitter, and Instagram pages at Let's Pharmonize to view videos and images relevant to every episode! If you have any questions, comments, or even corrections, e-mail us at pharmonization@gmail.com. PLEASE READ: Shane, Mickey, Cal and Justin are NOT medical professionals. DO NOT USE the information presented in this podcast to aid in your own personal health or medicinal benefit. This is a light-hearted podcast that should not be taken with the same seriousness as your own personal health. A special thanks to Kelly Kerr for creating the music used in the intro and outro. Additional Music from Pixabay and Fesliyan Studios Learn more about your ad choices. Visit megaphone.fm/adchoices

As pharmacy expands to include more healthcare services many of them are branching off into diet, nutrition and weight loss programs. As they do this it may be prudent for them to dig a bit deeper than the traditional thinking about calorie counting and the BMI index. Linda Tucker, an independent health counselor shares some ideas on rapidly expanding ideas pharmacy owners should know about. In this episode Tucker shares her reasons why she feels trying to help patient improve their health should include learning about the Heath at Every Size and Intuitive eating movements. Whether you agree or disagree, millions of Americans are involved and as a healthcare professional she feels every pharmacist should at least be aware of them. Learn more about your ad choices. Visit megaphone.fm/adchoices

What does public health mean to you? Public health is the intersection where individual patient decisions meet public policy, where medicine meets law. Bio Output Medical was founded by Dr. Jay K Joshi as an Intern managing complex Intensive Care Unit (ICU) patients. Concerned by the limitations of manual urine output measurements and subsequent kidney care management, he set out to develop a technology that would improve the measuring and recording of urine output to help patients with kidney injury or kidney failure. Born out of a need to improve urine output measurements, Output Medical is passionate about kidney management and saving patient lives. Abnormally low urine output (known as oliguria) is a leading indicator of acute kidney injury (AKI) among ICU patients. AKI is a rapid and dangerous loss of kidney function which seriously impacts a patient's quality of care: it increases mortality, cost of care, length of stay, and readmission. AKI occurs in 20% of all ICU admissions each year, meaning approximately two million patients in the U.S. for whom regular and automatic urine output monitoring could improve their health. The average additional cost of a patient with AKI is nearly $16,000, a significant cost to patients and hospitals. Learn more about your ad choices. Visit megaphone.fm/adchoices

According to the National Community Pharmacists Association (NCPA), community pharmacists are highly accessible health care professionals and 95% of Americans live within just 5 miles of a pharmacy. (https://ncpa.org/provider-status) And what APhA or American Pharmacist Association, the largest association of pharmacists in the US is doing is laser focusing on getting provider status for pharmacists. So why is that important when it comes to PGx as this is a PGx podcast? Pharmacists can order the PGx test when they see fit for their patients without the need of a clinician to sign that form.  Scott Knoer, MS, PharmD, FASHP, became the 13th Executive Vice President and Chief Executive Officer of the American Pharmacists Association in June 2020, after serving for nine years as the Chief Pharmacy Officer at the Cleveland Clinic. Dr. Knoer is a passionate advocate for patients and the profession of pharmacy. He has successfully lobbied boards of pharmacy in Ohio and Minnesota to allow the advancement of pharmacy practice, and he has led initiatives that changed Ohio and federal law related to the elevation of pharmacy practice and reducing the impact of drug shortages. He received his BA in psychology from Creighton University and his PharmD from the University of Nebraska. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of DarshanTalks Podcast, the host Darshan Kulkarni Pharm.D, MS, Esq. and Guest Speaker Lewis A. Grossman discuss the Right to Therapeutic Choice. Lewis A. Grossman's recently launched book "Choose Your Medicine: Freedom of Therapeutic Choice in America" on the freedom of medicine in the USA. Lewis Grossman, Author, Counsel at Covington & Burling LLP (https://www.cov.com/) and Professor of Law at American University, Washington College of Law, had spoken about government interference in the 19th century on the healthcare industry. The conversation started off with the expert explaining his newly launched book based on freedom of therapeutic choices in America that is affected in American law and policy. The compelled speech doctrine sets out the principle that the government cannot force an individual or group to support certain expressions, this was discussed with compelled action which initially the host gave an example of how cigarette advertisements portray and mention that cigarettes are injurious to health whilst asking the expert to share his insights over this topic. He explains his constitutional law perspective on this subject that what government can make you do and what it cannot, he also mentioned about commercial speech is not protected as supposed to political speech or artistic speech. The conversation also included an interesting topic of off-labeling drugs and ancient drugs like hydroxychloroquine and ivermectin used to treat Covid-19. Furthermore, if the branded company would have endorsed or used these drugs the implications are discussed in this podcast. Also, the subject of monoclonal antibodies was discussed, monoclonal antibodies are proteins created in a lab. The proteins mimic your immune system and are meant to make COVID-19 disease milder in patients who are already sick. As per the expert, the monoclonal antibodies are disseminated by EUA and not FDA approved, highly expensive. They talked about the history of sciences, pharma history, and much more differentiating with the bio-hacking, monoclonal antibodies, hydroxychloroquine, and ivermectin being in the same spectrum. In the mid-segment, what constitutes to be bad-advertisements and how the FDA now is disseminating about bad-ad to the medical industry. Previous Podcast with Lewis A. Grossman: https://www.youtube.com/watch?v=rTRKF... Connect with Lewis A. Grossman: On LinkedIn: https://www.linkedin.com/in/lewis-a-g... Email: lewisg@wcl.american.edu Lewis A. Grossman book link: https://global.oup.com/academic/produ... https://www.amazon.com/dp/0190612754/... Connect with us: Website: http://www.darshantalks.com Law Firm: http://www.kulkarnilawfirm.com Twitter: https://twitter.com/darshantalks ---- Disclaimers: 1. This discussion is merely an oral discussion and should not be relied upon solely on its own to support any conclusion of law or fact. 2. The discussion does not and should not reflect any individual products status as safe, efficacious, adulterated, or misbranded or meeting or not meeting expectations at a local, state, federal, or international agency or organization. 3. The discussion should not be construed to be complete advice that is right for you and may not necessarily represent a specific product. 4. This discussion is provided for general educational purposes and should not be construed as legal advice, regulatory advice, or medical advice. 5. This does not create an attorney-client relationship. Learn more about your ad choices. Visit megaphone.fm/adchoices